A Study of Aleglitazar in Patients With Type 2 Diabetes

Clinical trial NCT00388518 · COMPLETED

Trial details

NCT number: NCT00388518
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2006-11-01
Primary completion: 2008-03-01
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.